IgG3 Fc产品信息
英文名称:Immunoglobulin G
中文名称:免疫球蛋白G
靶点别称:IgG3 Fc
物种:Human/Mouse
属性:Protein
标记:Unconjugated
内毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
纯度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制剂(Formulation)
Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重构方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存储(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
IgG3 Fc分子背景
免疫球蛋白G3(IgG3)是许多由有效B细胞产生和分泌的免疫球蛋白G的成员。在胃蛋白酶切割后,IgG被分成两个F(ab),具有一个抗原结合位点和一个高度保守的Fc片段。Fc段具有高度保守的N-糖基化位点。Igγ-3链C区(IgG3 Fc/IGHG3)包含IgG3 H链的两个恒定区(CH2、CH3)。
关键字: IgG3 Fc;IgG3 Fc蛋白;IgG3 Fc受体蛋白;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。